This test is most useful if any of these apply to you.
If you sneeze around cats, wheeze near friends with pets, or break out in hives after a feline encounter, the standard story usually points to one allergen called Fel d 1. But a meaningful share of cat-allergic people also react to a second, less famous cat protein. Knowing whether your immune system targets this second protein can change how you interpret your symptoms, how you read cross-reactions with dogs and horses, and how you think about treatment.
This test measures Fel d 4 (Felis domesticus allergen 4) IgE (immunoglobulin E) in blood, an antibody that latches onto a protein cats release primarily into their saliva, which then spreads to fur and dander. In studies of cat-allergic adults, a substantial share carry IgE against Fel d 4, making it one of the more relevant cat allergens after Fel d 1. The result tells you not just whether you are sensitized to cats in general, but which molecules your immune system has actually picked a fight with.
Fel d 4 belongs to a family of small carrier proteins called lipocalins, the same family that produces important allergens in dogs and horses. Cats secrete this protein primarily in their saliva, where it spreads onto fur and skin during grooming and becomes airborne in dander. When your immune system flags Fel d 4 as a threat, it makes IgE antibodies that sit on mast cells (the histamine-releasing cells lining your airways and skin), ready to trigger an allergic reaction on next exposure.
In cat-allergic adults, Fel d 4 binds notable amounts of IgE and has been shown to trigger basophil cells (immune cells that release histamine) at low concentrations, meaning it has real allergenic punch and not just a positive lab reading. This puts Fel d 4 in a different category from cat proteins that show up on tests but rarely cause symptoms.
How common Fel d 4 IgE is depends heavily on who is being tested. In Korean adults sensitized to cat dander, about 21 percent had measurable Fel d 4-specific IgE. In Russian cat-allergic patients, the rate was much higher at roughly 39 percent, while in a Central European allergy population it was around 5 percent. In one cohort, 35 percent of cat-allergic individuals had a non-Fel d 1 allergen as their dominant IgE-binding target, with Fel d 4 being one of the main contributors. In population studies of children, however, Fel d 1 dominates the picture, and only a small percentage of sensitized children had IgE to Fel d 4 without also having IgE to Fel d 1.
What this means for you: if you have known cat allergy, there is a meaningful chance Fel d 4 is part of the story, with the likelihood varying widely by geography and methodology. If you have no symptoms but want to map your immune profile, a negative Fel d 4 result is more common than a positive one, especially earlier in life.
Fel d 4 IgE is not just a lab curiosity. It has been linked to respiratory and skin symptoms in cat-allergic patients and is associated with higher blood eosinophil counts (a type of white cell involved in allergic inflammation) and bronchial inflammation in young people with severe asthma. When Fel d 4 sensitization shows up alongside Fel d 1 sensitization, the combination tracks with current asthma and active asthma symptoms more strongly than either alone, even at moderate Fel d 4 sensitization levels.
In a Russian microarray study of cat-allergic patients, testing for IgE against Fel d 1, Fel d 2, and Fel d 4 identified most symptomatic patients, with a strong correlation (around 0.94) to standard cat extract testing. This suggests Fel d 4, alongside Fel d 1 and Fel d 2, helps round out the picture of who is genuinely allergic beyond what Fel d 1 alone reveals.
The more cat components you react to, the higher your risk of allergic symptoms and asthma. Being sensitized to multiple cat allergens, including Fel d 4, tracks with more severe disease in children with cat-related symptoms. In a study of young teens, the less abundant cat allergens (including Fel d 4) were more strongly linked to asthma than Fel d 1 alone, partly because the body makes less protective IgG4 antibody against them.
What this means for you: a positive Fel d 4 result alongside Fel d 1 reactivity is a stronger signal that cat exposure is contributing to your respiratory disease than a positive Fel d 1 result alone. It is also a reason to take cat-related asthma symptoms more seriously, not less.
Fel d 4 is a lipocalin, the same protein family that produces Can f 6 in dogs and Equ c 1 in horses. IgE to Fel d 4 often correlates with IgE to these dog and horse proteins. Cross-reactivity has also been described with other lipocalins, including Can f 2 (dog) and rodent allergens such as MUP1 (mouse) and Rat n 1 (rat). The cross-reactivity is selective rather than wholesale: some people sensitized to Fel d 4 react strongly to dog and horse lipocalins; others react only to cats.
What this means for you: a positive Fel d 4 result is a reason to think carefully before assuming you can swap a cat for a dog or spend time around horses without consequence. If you are weighing pet choices or exposure decisions, your Fel d 4 result is most useful when interpreted alongside specific dog and horse component tests rather than in isolation.
A traditional cat allergy panel uses whole cat extract, which captures sensitization to any cat protein but cannot tell you which one. Fel d 1, the major cat allergen, accounts for most cat-related symptoms in most patients and is usually the first molecule to test. But relying on Fel d 1 alone misses people whose symptoms are driven significantly by Fel d 4 or Fel d 7.
Cumulative IgE across multiple cat molecules correlates better with complex, multi-organ symptoms than any single component. That is why Fel d 4 is most valuable as part of a component panel that also includes Fel d 1, Fel d 2, and Fel d 7, particularly when symptoms are severe, atypical, or involve multiple furry animals.
A single reading tells you whether Fel d 4 IgE is detectable today. What it cannot tell you is whether your sensitization is rising, falling, or stable. IgE responses to cat components evolve throughout childhood and shift in adulthood with exposure changes. In college students with decreased cat exposure, cat-specific antibody levels measurably changed, and starting cat allergen immunotherapy reshapes the IgE/IgG balance over months to a year.
Major allergy societies have not published specific retesting intervals for individual cat allergen components, so cadence is a judgment call. For someone actively tracking allergy, a reasonable approach is a baseline test, a follow-up reading some months after a meaningful exposure change (moving in with a cat, removing a cat from the home, starting immunotherapy), and periodic monitoring thereafter if you have ongoing symptoms. Trends matter more than a single number, because they reveal whether your immune system is calming down, holding steady, or escalating.
If your Fel d 4 IgE comes back positive but you have no cat symptoms, do not panic. Sensitization without symptoms is common, especially in polysensitized people. Pair the result with other cat components (Fel d 1, Fel d 2, Fel d 7) to map the full picture, and consider testing dog (Can f 6) and horse (Equ c 1) lipocalins if you have exposure to those animals or unexplained symptoms around them.
If your Fel d 4 IgE is positive and you have respiratory or skin symptoms around cats, the result strengthens the case for evaluation by an allergist, particularly if you are considering allergen immunotherapy or trying to decide whether avoidance, environmental controls, or biologic treatments make sense. A negative Fel d 4 result with cat symptoms does not rule out cat allergy: it simply means Fel d 1 or another component is more likely driving your reactions.
A few practical caveats to keep in mind when reading your Fel d 4 IgE number:
Cat (Fel d 4) IgE is best interpreted alongside these tests.
Cat (Fel d 4) IgE is included in these pre-built panels.